| Nov 20 |
Wall Street Analysts Think Corcept (CORT) Could Surge 37.91%: Read This Before Placing a Bet
|
| Nov 11 |
Zacks Industry Outlook Madrigal, Corcept, Catalyst Larimar and Theravance
|
| Nov 8 |
5 Small Drug Stocks to Buy as Trump Gets Re-Elected
|
| Nov 7 |
Catalyst Pharmaceuticals, Inc. (CPRX) Hit a 52 Week High, Can the Run Continue?
|
| Nov 6 |
Corcept Therapeutics Stock Surges 61% in 2024: A Must Buy?
|
| Nov 6 |
3 US Growth Stocks With Insider Ownership As High As 37%
|
| Nov 5 |
Here is Why Growth Investors Should Buy Corcept (CORT) Now
|
| Nov 5 |
Corcept (CORT) Upgraded to Strong Buy: Here's Why
|
| Nov 5 |
Best Momentum Stocks to Buy for November 5th
|
| Nov 5 |
Corcept Therapeutics Incorporated (CORT) Soars to 52-Week High, Time to Cash Out?
|
